Cargando…

A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients

Depression is one of the common psychiatric problems in growing world population caused by long-term stressful events that may trigger the down regulation of neurogenesis. The pathogenesis of depression initially relies on serotonin deficiency which is associated with depressive feelings. Tryptophan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Saara, Azhar, Arfa, Tikmani, Prashant, Rafique, Hamna, Khan, Asra, Mesiya, Hanif, Saeed, Humera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547202/
https://www.ncbi.nlm.nih.gov/pubmed/36217471
http://dx.doi.org/10.1016/j.heliyon.2022.e10774
_version_ 1784805211948187648
author Ahmad, Saara
Azhar, Arfa
Tikmani, Prashant
Rafique, Hamna
Khan, Asra
Mesiya, Hanif
Saeed, Humera
author_facet Ahmad, Saara
Azhar, Arfa
Tikmani, Prashant
Rafique, Hamna
Khan, Asra
Mesiya, Hanif
Saeed, Humera
author_sort Ahmad, Saara
collection PubMed
description Depression is one of the common psychiatric problems in growing world population caused by long-term stressful events that may trigger the down regulation of neurogenesis. The pathogenesis of depression initially relies on serotonin deficiency which is associated with depressive feelings. Tryptophan (TRP) depletion participate crucial role in inducing depressive symptoms. Long-term reduction of 5-HT may disseminate to high sensitivity of MDD and alters the level of BDNF. Some studies have also revealed the strong association between excessive neuroinflammation and BDNF levels, due the release of pro-inflammatory cytokines. The treatment approach through FDA approved medicine has their own merits and drawbacks. Therefore, herbal alternatives have recently garnered attention for their effectiveness against depression. However, evidence-based synergic effects of antidepressant with different herbal agents are limited. The purpose of this study was to assess the synergistic effects of two well-known herbs, chamomile and saffron, as an adjuvant therapy in patients with mild to moderate depression. The present study was study randomized, open, blinded trial and comprised of 120 participants randomly allocated to control (n = 60) and test (n = 60). After consent, the patient health questionnaire- 9 (PHQ-9) was filled to obtain depression scores. The test participants were received herbal tea sachets twice a day for one month (20 mg Chamomile and 1 mg Saffron/sachet) along with routine medicines, while control participants were received only allopathic medications. Blood samples were taken before and after the treatment. The depressive symptoms improved significantly with both treatments. The effect of herbs enhanced the efficacy of medications and significantly improved PHQ-9 scale and BDNF while reduced the inflammatory markers (CRP) and TRP level in plasma thereby increased the availability of TRP in brain. It has been concluded that the herbal adjuvant therapy produced long term improvement against depression and enhanced the efficacy of allopathic treatment.
format Online
Article
Text
id pubmed-9547202
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95472022022-10-09 A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients Ahmad, Saara Azhar, Arfa Tikmani, Prashant Rafique, Hamna Khan, Asra Mesiya, Hanif Saeed, Humera Heliyon Research Article Depression is one of the common psychiatric problems in growing world population caused by long-term stressful events that may trigger the down regulation of neurogenesis. The pathogenesis of depression initially relies on serotonin deficiency which is associated with depressive feelings. Tryptophan (TRP) depletion participate crucial role in inducing depressive symptoms. Long-term reduction of 5-HT may disseminate to high sensitivity of MDD and alters the level of BDNF. Some studies have also revealed the strong association between excessive neuroinflammation and BDNF levels, due the release of pro-inflammatory cytokines. The treatment approach through FDA approved medicine has their own merits and drawbacks. Therefore, herbal alternatives have recently garnered attention for their effectiveness against depression. However, evidence-based synergic effects of antidepressant with different herbal agents are limited. The purpose of this study was to assess the synergistic effects of two well-known herbs, chamomile and saffron, as an adjuvant therapy in patients with mild to moderate depression. The present study was study randomized, open, blinded trial and comprised of 120 participants randomly allocated to control (n = 60) and test (n = 60). After consent, the patient health questionnaire- 9 (PHQ-9) was filled to obtain depression scores. The test participants were received herbal tea sachets twice a day for one month (20 mg Chamomile and 1 mg Saffron/sachet) along with routine medicines, while control participants were received only allopathic medications. Blood samples were taken before and after the treatment. The depressive symptoms improved significantly with both treatments. The effect of herbs enhanced the efficacy of medications and significantly improved PHQ-9 scale and BDNF while reduced the inflammatory markers (CRP) and TRP level in plasma thereby increased the availability of TRP in brain. It has been concluded that the herbal adjuvant therapy produced long term improvement against depression and enhanced the efficacy of allopathic treatment. Elsevier 2022-09-30 /pmc/articles/PMC9547202/ /pubmed/36217471 http://dx.doi.org/10.1016/j.heliyon.2022.e10774 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Ahmad, Saara
Azhar, Arfa
Tikmani, Prashant
Rafique, Hamna
Khan, Asra
Mesiya, Hanif
Saeed, Humera
A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title_full A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title_fullStr A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title_full_unstemmed A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title_short A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
title_sort randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547202/
https://www.ncbi.nlm.nih.gov/pubmed/36217471
http://dx.doi.org/10.1016/j.heliyon.2022.e10774
work_keys_str_mv AT ahmadsaara arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT azhararfa arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT tikmaniprashant arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT rafiquehamna arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT khanasra arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT mesiyahanif arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT saeedhumera arandomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT ahmadsaara randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT azhararfa randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT tikmaniprashant randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT rafiquehamna randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT khanasra randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT mesiyahanif randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients
AT saeedhumera randomizedclinicaltrialtotestefficacyofchamomileandsaffronforneuroprotectiveandantiinflammatoryresponsesindepressivepatients